n-3 Fatty Acid Biomarkers and Incident Type 2 Diabetes: An Individual Participant-Level Pooling Project of 20 Prospective Cohort Studies.
Frank QianAndres V Ardisson KoratFumiaki ImamuraMatti MarklundNathan TintleJykri K VirtanenXia ZhouJulie K BassettHeidi LaiYoichiro HirakawaKuo-Liong ChienAlexis C WoodMaria LankinenRachel A MurphyCecilia SamieriKamalita PertiwiVanessa Derenji de MelloWeihua GuanNita G ForouhiNick WarehamInterAct Consortium Frank B HuUlf RiserusLars LindWilliam S HarrisAladdin H ShadyabJennifer G RobinsonLyn M SteffenAllison HodgeGraham G GilesToshiharu NinomiyaMatti UusitupaJaakko TuomilehtoJaana LindströmMarkku LaaksoDavid S SiscovickCatherine HelmerJohanna M GeleijnseJason H Y WuAmanda FrettsRozenn N LemaitreRenata MichaDariush MozaffarianFrank B Hunull nullPublished in: Diabetes care (2021)
Higher circulating biomarkers of seafood-derived n-3 fatty acids, including EPA, DPA, DHA, and their sum, were associated with lower risk of T2D in a global consortium of prospective studies. The biomarker of plant-derived ALA was not significantly associated with T2D risk.